Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy

被引：0
|
作者：
Kazumasa Fujitani
Shigeyuki Tamura
Yutaka Kimura
Takeshi Tsuji
Jin Matsuyama
Shohei Iijima
Hiroshi Imamura
Kentaro Inoue
Kenji Kobayashi
Yukinori Kurokawa
Toshio Shimokawa
Toshimasa Tsujinaka
Hiroshi Furukawa
机构：
[1] Osaka National Hospital,Department of Surgery
[2] Kansai Rosai Hospital,Department of Surgery
[3] NTT West Osaka Hospital,Department of Surgery
[4] Wakayama Rosai Hospital,Department of Surgery
[5] Yao Municipal Hospital,Department of Surgery
[6] Minoh City Hospital,Department of Surgery
[7] Sakai Municipal Hospital,Department of Surgery
[8] Kansai Medical University,Department of Surgery
[9] Kinki Central Hospital,Department of Surgery
[10] Osaka University Medical School,Department of Surgery
[11] Yamanashi University,Graduate School of Medicine and Engineering
[12] Kinki University Medical School,Department of Surgery
来源：
Gastric Cancer | 2014年 / 17卷
关键词：
Adjuvant chemotherapy; Docetaxel; Gastric cancer; Three-year survival; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：348 / 353
页数：5
相关论文
共 50 条
  • [1] Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy
    Fujitani, Kazumasa
    Tamura, Shigeyuki
    Kimura, Yutaka
    Tsuji, Takeshi
    Matsuyama, Jin
    Iijima, Shohei
    Imamura, Hiroshi
    Inoue, Kentaro
    Kobayashi, Kenji
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    GASTRIC CANCER, 2014, 17 (02) : 348 - 353
  • [2] Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
    Ryohei, Kawabata
    Kazumasa, Fujitani
    Shigeyuki, Tamura
    Yutaka, Kimura
    Hiroshi, Imamura
    Junya, Fujita
    Jin, Matsuyama
    Shohei, Iijima
    Shugo, Ueda
    Yukinori, Kurokawa
    Daisuke, Sakai
    Toshio, Shimokawa
    Toshimasa, Tsujinaka
    Hiroshi, Furukawa
    Taroh, Satoh
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] FIVE-YEAR OUTCOMES OF A PHASE II STUDY OF ADJUVANT CHEMOTHERAPY WITH S-1 PLUS DOCETAXEL FOR STAGE III GASTRIC CANCER AFTER CURATIVE D2 GASTRECTOMY
    Shigeyuki, Tamura
    Kazumasa, Fujitani
    Yutaka, Kimura
    Takeshi, Tsuji
    Shohei, Iijima
    Jin, Matsuyama
    Hiroshi, Imamura
    Kentarou, Inoue
    Kenji, Kobayashi
    Yukinori, Kurokawa
    Toshio, Shimokawa
    Toshimasa, Tsujinaka
    Hiroshi, Furukawa
    ANNALS OF ONCOLOGY, 2014, 25 : 40 - 40
  • [4] Phase II Feasibility Study of Adjuvant S-1 plus Docetaxel for Stage III Gastric Cancer Patients after Curative D2 Gastrectomy
    Tamura, Shigeyuki
    Fujitani, Kazumasa
    Kimura, Yutaka
    Tsuji, Takeshi
    Matsuyama, Jin
    Iijima, Shohei
    Imamura, Hiroshi
    Inoue, Kentaro
    Kobayashi, Kenji
    Kurokawa, Yukinori
    Furukawa, Hiroshi
    ONCOLOGY, 2011, 80 (5-6) : 296 - 300
  • [5] Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
    Fujitani, Kazumasa
    Tamura, Shigeyuki
    Kimura, Yutaka
    Matsuyama, Jin
    Imamura, Hiroshi
    Yamamoto, Kazuyoshi
    Fujita, Junya
    Iijima, Shohei
    Ueda, Shugo
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Satoh, Taroh
    GASTRIC CANCER, 2020, 23 (03) : 520 - 530
  • [6] Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
    Kazumasa Fujitani
    Shigeyuki Tamura
    Yutaka Kimura
    Jin Matsuyama
    Hiroshi Imamura
    Kazuyoshi Yamamoto
    Junya Fujita
    Shohei Iijima
    Shugo Ueda
    Yukinori Kurokawa
    Toshio Shimokawa
    Taroh Satoh
    Gastric Cancer, 2020, 23 : 520 - 530
  • [7] Three-year outcomes of two phase II studies of adjuvant chemotherapy with S-1 plus oxaliplatin or capecitabine plus oxaliplatin in patients with stage III gastric cancer after D2 gastrectomy
    Nakamura, Yoshiaki
    Yamanaka, Takeharu
    Chin, Keisho
    Cho, Haruhiko
    Katai, Hitoshi
    Terashima, Masanori
    Ito, Seiji
    Hirao, Motohiro
    Yoshida, Kazuhiro
    Oki, Eiji
    Sasako, Mitsuru
    Emi, Yasunori
    Bando, Hideaki
    Kawashima, Yoshiyuki
    Fukunaga, Tetsu
    Gotoh, Masahiro
    Ishibashi, Takako
    Shitara, Kohei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [8] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0604).
    Matsuyama, Jin
    Tamura, Shigeyuki
    Fujitani, Kazumasa
    Kimura, Yutaka
    Tsuji, Takeshi
    Iijima, Shohei
    Imamura, Hiroshi
    Inoue, Kentaro
    Kobayashi, Kenji
    Kurokawa, Yukinori
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [9] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 1002)
    Matsuyama, Jin
    Fujitani, Kazumasa
    Tamura, Shigeyuki
    Kimura, Yutaka
    Imamura, Hiroshi
    Fujita, Junya
    Iljima, Shohei
    Ueda, Shugo
    Shimokawa, Toshio
    Kurokawa, Yukinori
    Satoh, Taroh
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0604)
    Fujitani, K.
    Tamura, S.
    Kimura, Y.
    Tsuji, T.
    Matsuyama, J.
    Iijima, S.
    Imamura, H.
    Kurokawa, Y.
    Tsujinaka, T.
    Furukawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345